564 related articles for article (PubMed ID: 11729018)
21. Differences in regional brain metabolism associated with marijuana abuse in methamphetamine abusers.
Voytek B; Berman SM; Hassid BD; Simon SL; Mandelkern MA; Brody AL; Monterosso J; Ling W; London ED
Synapse; 2005 Aug; 57(2):113-5. PubMed ID: 15906384
[No Abstract] [Full Text] [Related]
22. Striatal Dopamine D2/D3 Receptor Availability Is Associated with Executive Function in Healthy Controls but Not Methamphetamine Users.
Ballard ME; Dean AC; Mandelkern MA; London ED
PLoS One; 2015; 10(12):e0143510. PubMed ID: 26657223
[TBL] [Abstract][Full Text] [Related]
23. The orbitofrontal cortex in methamphetamine addiction: involvement in fear.
Goldstein RZ; Volkow ND; Chang L; Wang GJ; Fowler JS; Depue RA; Gur RC
Neuroreport; 2002 Dec; 13(17):2253-7. PubMed ID: 12488806
[TBL] [Abstract][Full Text] [Related]
24. Cocaine dependence and d2 receptor availability in the functional subdivisions of the striatum: relationship with cocaine-seeking behavior.
Martinez D; Broft A; Foltin RW; Slifstein M; Hwang DR; Huang Y; Perez A; Frankle WG; Cooper T; Kleber HD; Fischman MW; Laruelle M
Neuropsychopharmacology; 2004 Jun; 29(6):1190-202. PubMed ID: 15010698
[TBL] [Abstract][Full Text] [Related]
25. Emotion dysregulation and amygdala dopamine D2-type receptor availability in methamphetamine users.
Okita K; Ghahremani DG; Payer DE; Robertson CL; Dean AC; Mandelkern MA; London ED
Drug Alcohol Depend; 2016 Apr; 161():163-70. PubMed ID: 26880595
[TBL] [Abstract][Full Text] [Related]
26. Changes in brain glucose metabolism in cocaine dependence and withdrawal.
Volkow ND; Fowler JS; Wolf AP; Hitzemann R; Dewey S; Bendriem B; Alpert R; Hoff A
Am J Psychiatry; 1991 May; 148(5):621-6. PubMed ID: 2018164
[TBL] [Abstract][Full Text] [Related]
27. A preliminary study: novelty seeking, frontal executive function, and dopamine receptor (D2) TaqI A gene polymorphism in patients with methamphetamine dependence.
Han DH; Yoon SJ; Sung YH; Lee YS; Kee BS; Lyoo IK; Renshaw PF; Cho SC
Compr Psychiatry; 2008; 49(4):387-92. PubMed ID: 18555060
[TBL] [Abstract][Full Text] [Related]
28. Cerebral glucose metabolism and D2/D3 receptor availability in young adults with cannabis dependence measured with positron emission tomography.
Sevy S; Smith GS; Ma Y; Dhawan V; Chaly T; Kingsley PB; Kumra S; Abdelmessih S; Eidelberg D
Psychopharmacology (Berl); 2008 May; 197(4):549-56. PubMed ID: 18270689
[TBL] [Abstract][Full Text] [Related]
29. Dose-dependent frontal hypometabolism on FDG-PET in methamphetamine abusers.
Kim YT; Lee SW; Kwon DH; Seo JH; Ahn BC; Lee J
J Psychiatr Res; 2009 Sep; 43(14):1166-70. PubMed ID: 19394959
[TBL] [Abstract][Full Text] [Related]
30. No elevated D2 dopamine receptors in neuroleptic-naive schizophrenic patients revealed by positron emission tomography and [11C]N-methylspiperone.
Nordström AL; Farde L; Eriksson L; Halldin C
Psychiatry Res; 1995 Aug; 61(2):67-83. PubMed ID: 7480390
[TBL] [Abstract][Full Text] [Related]
31. Association between age-related decline in brain dopamine activity and impairment in frontal and cingulate metabolism.
Volkow ND; Logan J; Fowler JS; Wang GJ; Gur RC; Wong C; Felder C; Gatley SJ; Ding YS; Hitzemann R; Pappas N
Am J Psychiatry; 2000 Jan; 157(1):75-80. PubMed ID: 10618016
[TBL] [Abstract][Full Text] [Related]
32. Similarity between obesity and drug addiction as assessed by neurofunctional imaging: a concept review.
Wang GJ; Volkow ND; Thanos PK; Fowler JS
J Addict Dis; 2004; 23(3):39-53. PubMed ID: 15256343
[TBL] [Abstract][Full Text] [Related]
33. Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET.
Sekine Y; Iyo M; Ouchi Y; Matsunaga T; Tsukada H; Okada H; Yoshikawa E; Futatsubashi M; Takei N; Mori N
Am J Psychiatry; 2001 Aug; 158(8):1206-14. PubMed ID: 11481152
[TBL] [Abstract][Full Text] [Related]
34. Effect of Exercise Training on Striatal Dopamine D2/D3 Receptors in Methamphetamine Users during Behavioral Treatment.
Robertson CL; Ishibashi K; Chudzynski J; Mooney LJ; Rawson RA; Dolezal BA; Cooper CB; Brown AK; Mandelkern MA; London ED
Neuropsychopharmacology; 2016 May; 41(6):1629-36. PubMed ID: 26503310
[TBL] [Abstract][Full Text] [Related]
35. Low dopamine striatal D2 receptors are associated with prefrontal metabolism in obese subjects: possible contributing factors.
Volkow ND; Wang GJ; Telang F; Fowler JS; Thanos PK; Logan J; Alexoff D; Ding YS; Wong C; Ma Y; Pradhan K
Neuroimage; 2008 Oct; 42(4):1537-43. PubMed ID: 18598772
[TBL] [Abstract][Full Text] [Related]
36. D2 dopamine receptor polymorphism and brain regional glucose metabolism.
Noble EP; Gottschalk LA; Fallon JH; Ritchie TL; Wu JC
Am J Med Genet; 1997 Apr; 74(2):162-6. PubMed ID: 9129716
[TBL] [Abstract][Full Text] [Related]
37. Reward deficiency syndrome: genetic aspects of behavioral disorders.
Comings DE; Blum K
Prog Brain Res; 2000; 126():325-41. PubMed ID: 11105655
[TBL] [Abstract][Full Text] [Related]
38. Decreased thalamic D2/D3 receptor binding in drug-naive patients with schizophrenia: a PET study with [11C]FLB 457.
Talvik M; Nordström AL; Olsson H; Halldin C; Farde L
Int J Neuropsychopharmacol; 2003 Dec; 6(4):361-70. PubMed ID: 14604451
[TBL] [Abstract][Full Text] [Related]
39. PET imaging reveals brain functional changes in internet gaming disorder.
Tian M; Chen Q; Zhang Y; Du F; Hou H; Chao F; Zhang H
Eur J Nucl Med Mol Imaging; 2014 Jul; 41(7):1388-97. PubMed ID: 24737115
[TBL] [Abstract][Full Text] [Related]
40. Dopamine transporters and cognitive function in methamphetamine abuser after a short abstinence: A SPECT study.
Chou YH; Huang WS; Su TP; Lu RB; Wan FJ; Fu YK
Eur Neuropsychopharmacol; 2007 Jan; 17(1):46-52. PubMed ID: 16842981
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
